CVRx marks 25th Barostim implant milestone at UNC Medical Center Chapel Hill

CVRx marks 25th Barostim implant milestone at UNC Medical Center Chapel Hill
CVRx reaches 25th Barostim milestone

CVRx has announced the successful completion of the 25th Barostim implant at UNC Medical Center in Chapel Hill.

The accomplishment recognizes the contributions of Dr. William Tripp Mostertz, nurse practitioners Emily Baker and Sarah Waters, cardiac device technician Keosha McKinney, and the broader medical team. The Barostim device provides innovative therapy options for patients, underscoring the collaboration between clinical experts and device developers in advancing patient care.

CVRx reported a 20 percent increase in total revenue for the first quarter, with U.S. operations rising 22 percent, according to a recent earnings update. The company also began patient enrollment in its BENEFIT-HF clinical trial at North Central Heart, targeting one of the largest studies in cardiac device research. These developments come as CVRx continues to grow its presence in the cardiac device sector.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.